CD8A and neoplasm: Intriguingly, although dispensable for PsV-induced initial tumour eradication, tumour antigen (hCEA)-specific CD8+ T-cell response plays a role in preventing tumour relapse, thereby further prolonging the lifespan of the tumour-bearing mice.